Target intelligence / Profile preview

Physiological iron-binding protein pool

Molecular classification
Other, Metalloprotein, Transport protein, Storage protein
01

Overview

The physiological iron-binding protein pool refers to the ensemble of proteins that sequester, transport, and utilize iron to maintain systemic iron homeostasis and prevent oxidative damage [1][2]. This pool includes transport proteins like transferrin, storage proteins such as ferritin and hemosiderin, and functional proteins like hemoglobin, myoglobin, and various cytochromes [2][3]. Because free iron is chemically reactive and can catalyze the formation of harmful free radicals via Fenton chemistry, these proteins are essential for safely managing iron levels throughout the body [1]. In therapeutic contexts, this pool is targeted by iron chelators, such as deferoxamine and deferasirox, to treat iron overload disorders like hereditary hemochromatosis or secondary iron overload from frequent blood transfusions [4]. These drugs work by competing for iron bound within the pool, forming stable complexes that are subsequently excreted [4]. Conversely, iron replacement therapies target this pool to treat iron deficiency anemia by providing the necessary substrate for hemoglobin synthesis and replenishing depleted storage sites [3]. Monitoring this pool is clinically vital, using biomarkers like serum ferritin and transferrin saturation to guide treatment for both deficiency and overload states [2][3].

Other names
Iron-binding proteinsIron transport and storage proteinsSiderophilinsMetalloprotein pool
02

Mechanism of action

Iron chelators bind to ferric iron within the protein pool to form stable, excretable complexes, while iron supplements provide elemental iron to saturate these proteins for hemoglobin synthesis and storage.

03

Biological functions

Iron homeostasisOxygen transportIron storageIron transportElectron transport
04

Disease associations

Iron deficiency anemiaHemochromatosisThalassemiaAnemia of chronic diseaseSideroblastic anemia
05

Safety considerations

Iron toxicity (overload)Gastrointestinal distressNephrotoxicity (with chelators)Agranulocytosis (with deferiprone)Hypersensitivity and anaphylaxis (with intravenous iron)
06

Interacting drugs

Deferoxamine

5 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Total iron-binding capacity (TIBC)HemoglobinSoluble transferrin receptor (sTfR)

Beyond the preview

Go deeper on Physiological iron-binding protein pool.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological iron-binding protein pool.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call